Skip to search formSkip to main contentSkip to account menu

SR 46349B

Known as: SR-46349B, 2-Propen-1-one, 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)-, O-(2-(dimethylamino)ethyl)oxime, (Z,E)-, (E)-2-butenedioate (2:1) (salt), SR 46349 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Several agents have been shown to improve sleep induction and/or maintenance in patients with primary or comorbid insomnia. These… 
2005
2005
RationaleThe selective serotonin reuptake inhibitors (SSRIs) and the serotonin and noradrenaline reuptake inhibitors (SNRIs… 
1995
1995
SR 46349B is a potent and selective 5-HT{sub 2} receptor antagonist (Kd =1.2 nM) which is currently being evaluated as an… 
1993
1993
Summary Current thrombolytic strategies have a number of important shortcomings including resistance to recanalization and…